Home
Conditions
Endocrine Gland Neoplasms

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,073 public trials 1,365 recruiting studies

Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Active, Not Recruiting

A Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer

NCT02657551

Conditions: Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +5 more
Locations: Yale Cancer Center New Haven, Connecticut, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Active, Not Recruiting

A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to Treatment

NCT05241834

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations: UCLA Medical Center Los Angeles, California, United States

UCSF Medical Center at Mission Bay San Francisco, California, United States

Emory University Atlanta, Georgia, United States

University of Chicago Medicine-Comprehensive Cancer Center Chicago, Illinois, United States

View all 16 locations

View Trial Details

Active, Not Recruiting

Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer

NCT05141643

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, Not Recruiting

Surufatinib Combined With Sintilimab and AG in First-line Therapy of Patients With Locally Advanced or Metastatic Pancreatic Cancer

NCT05481476

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +5 more
Locations: Cancer center of SunYat-sen University Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer

NCT05669482

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +14 more
Locations: UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

University of Chicago Chicago, Illinois, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

University of Michigan Cancer Center Ann Arbor, Michigan, United States

View Trial Details

Active, Not Recruiting

A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer

NCT01896479

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +16 more
Locations: St Leonards, New South Wales, Australia

Herston, Queensland, Australia

Kurralta Park, South Australia, Australia

Parkville, Victoria, Australia

View all 49 locations

View Trial Details

Active, Not Recruiting

Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer

NCT03907852

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +38 more
Locations: University of California, San Francisco San Francisco, California, United States

University of Miami Sylvester Cancer Center Miami, Florida, United States

University of Chicago Medical Center Chicago, Illinois, United States

National Cancer Institute Bethesda, Maryland, United States

View Trial Details

Active, Not Recruiting

The Future Management of Patients With Neoplasms of the Gastro-intestinal Tract

NCT06728358

Conditions: Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +23 more
Locations: Policlinico Universitario Agostino Gemelli Rome, Lazio, Italy

View Trial Details

Active, Not Recruiting

Boost GVAX Pancreas Vaccine With or Without CY in Patients With Pancreas Cancer

NCT01088789

Conditions: Adenocarcinoma, Carcinoma, Digestive System Diseases, +10 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Active, Not Recruiting

A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma

NCT04111172

Conditions: Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage IIA Gastric Cancer AJCC v8, Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8, +50 more
Locations: Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Endocrine Gland Neoplasms

Endocrine Gland Neoplasms trial results

Related conditions